High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$10.1M
$10,136,356
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
10b5-1 Sell
2026-03-12
$2,756,468Large
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
10b5-1 Sell
|
2026-03-12 | $2,756,468Large | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
10b5-1 SellΔOwn -96.5%
2025-11-14
$4,158,442Large
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
10b5-1 SellΔOwn -96.5%
|
2025-11-14 | $4,158,442Large | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat
• Officer • EVP, Head of R&D
10b5-1 SellΔOwn -28.6%
2025-11-13
$3,221,445Largex3
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • EVP, Head of R&D
10b5-1 SellΔOwn -28.6%
|
2025-11-13 | $3,221,445Largex3 | S | Form 4 |